At what minimum age is Tessalon (benzonatate) indicated for use in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Minimum Age for Tessalon (Benzonatate) Use

Tessalon (benzonatate) should not be used in children under 10 years of age due to lack of established safety and efficacy, with documented fatal overdoses occurring in this age group. 1

FDA-Approved Age Indication

  • The FDA drug label explicitly states that "safety and effectiveness in children below the age of 10 have not been established." 1
  • The label further warns that "accidental ingestion resulting in death has been reported in children below age 10" and emphasizes to "keep out of reach of children." 1
  • The minimum approved age for benzonatate use is 10 years old. 1

Critical Safety Concerns in Young Children

Mortality Risk

  • Fatal overdoses have been documented in children as young as 2 years old, with death occurring within 15-20 minutes of ingestion in some cases. 2, 3
  • Between 1969-2010, five fatalities from accidental benzonatate ingestion occurred in children 2 years of age and younger. 3
  • Signs of overdose include seizures, cardiac arrest, coma, brain edema, apnea, and respiratory arrest—often developing within 15 minutes of ingestion. 3, 4

Exposure Patterns

  • From 2010-2018,83% of unintentional benzonatate exposures reported to poison control centers involved children 0-5 years old (2,718 cases). 2
  • The majority (77%) of pediatric benzonatate exposure cases were unintentional, highlighting the risk of accidental ingestion. 2

Mechanism of Toxicity

  • Benzonatate is chemically related to local anesthetics (procaine, tetracaine) and can cause temporary oral anesthesia if the capsule is broken or chewed. 1
  • Release of benzonatate in the mouth produces local anesthesia of oral mucosa and can lead to choking. 1
  • The drug has sodium channel-blocking properties similar to tetracaine, explaining its rapid and severe toxicity profile. 4

Clinical Guidance

Prescribing Considerations

  • Do not prescribe benzonatate for any child under 10 years of age, regardless of weight or clinical indication. 1
  • For children 10 years and older, maximum single dose is 200 mg with total daily dosage not exceeding 600 mg. 1
  • Counsel patients and caregivers to swallow capsules whole—never break, chew, dissolve, cut, or crush them. 1

Alternative Approaches

  • The American College of Chest Physicians recommends against over-the-counter cough suppressants in children due to significant morbidity and mortality risks. 5
  • While benzonatate showed effectiveness in 80% of cases with chronic cough in small pediatric case series, this limited evidence does not outweigh the substantial safety concerns in children under 10. 5

Common Pitfalls to Avoid

  • Do not assume benzonatate is safe in younger children simply because it is non-narcotic—its toxicity profile is severe and rapid. 3, 4
  • Do not extrapolate adult safety data to pediatric populations—children under 10 have documented increased risks of fatal toxicity. 6
  • Do not underestimate the risk of accidental ingestion—the gel capsule formulation is particularly attractive to young children and can be easily confused with candy. 2
  • Ensure proper storage counseling, as benzonatate prescriptions increased by 52% from 2004-2009, increasing exposure risk. 3

References

Research

Benzonatate toxicity in a teenager resulting in coma, seizures, and severe metabolic acidosis.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2012

Guideline

Benzonatate Safety and Efficacy in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Procaterol Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.